IIM
GILD icon

Intact Investment Management’s Gilead Sciences GILD Stock Holding History

Intact Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4M Buy
89,900
+39,300
+78% +$5.18M 0.32% 77
2026
Q1 		$7.05M Sell
50,600
-33,800
-40% -$4.73M 0.2% 106
2025
Q4 		$10.4M Buy
84,400
+42,600
+102% +$5.18M 0.3% 77
2025
Q3 		$4.64M Buy
41,800
+300
+0.7% +$34.1K 0.14% 127
2025
Q2 		$4.6M Sell
41,500
-4,300
-9% -$458K 0.16% 127
2025
Q1 		$5.13M Sell
45,800
-100
-0.2% -$10.3K 0.18% 120
2024
Q4 		$4.24M Sell
45,900
-93,500
-67% -$8.42M 0.15% 141
2024
Q3 		$11.7M Sell
139,400
-300
-0.2% -$22.9K 0.39% 68
2024
Q2 		$9.58M Buy
139,700
+53,300
+62% +$3.56M 0.36% 67
2024
Q1 		$6.33M Sell
86,400
-37,100
-30% -$2.85M 0.25% 89
2023
Q4 		$10M Hold
123,500
– – 0.4% 57
2023
Q3 		$9.26M Buy
123,500
+12,000
+11% +$923K 0.4% 54
2023
Q2 		$8.59M Sell
111,500
-43,700
-28% -$3.49M 0.35% 64
2023
Q1 		$12.9M Buy
155,200
+61,700
+66% +$5.11M 0.53% 46
2022
Q4 		$8.03M Sell
93,500
-117,400
-56% -$9.3M 0.35% 73
2022
Q3 		$13M Buy
210,900
+6,300
+3% +$397K 0.43% 49
2022
Q2 		$12.6M Buy
204,600
+2,200
+1% +$136K 0.4% 58
2022
Q1 		$12M Buy
202,400
+116,600
+136% +$7.45M 0.31% 72
2021
Q4 		$6.23M Hold
85,800
– – 0.16% 112
2021
Q3 		$5.99M Hold
85,800
– – 0.17% 106
2021
Q2 		$5.91M Hold
85,800
– – 0.17% 110
2021
Q1 		$5.54M Buy
85,800
+17,900
+26% +$1.15M 0.17% 112
2020
Q4 		$3.95M Hold
67,900
– – 0.13% 134
2020
Q3 		$4.29M Buy
67,900
+11,400
+20% +$791K 0.15% 114
2020
Q2 		$4.35M Sell
56,500
-76,000
-57% -$5.82M 0.16% 108
2020
Q1 		$9.89M Sell
132,500
-2,200
-2% -$152K 0.43% 52
2019
Q4 		$8.75M Buy
134,700
+7,100
+6% +$462K 0.3% 69
2019
Q3 		$8.09M Buy
127,600
+11,600
+10% +$758K 0.29% 72
2019
Q2 		$7.84M Sell
116,000
-1,300
-1% -$85.5K 0.28% 70
2019
Q1 		$7.63M Buy
117,300
+15,300
+15% +$1.02M 0.27% 74
2018
Q4 		$6.38M Hold
102,000
– – 0.26% 78
2018
Q3 		$7.88M Buy
102,000
+54,600
+115% +$4.12M 0.28% 71
2018
Q2 		$3.36M Hold
47,400
– – 0.12% 127
2018
Q1 		$3.57M Buy
+47,400
New +$3.77M 0.14% 115
2017
Q4 		– Sell
-4,100
Closed -$332K – 270
2017
Q3 		$332K Sell
4,100
-2,600
-39% -$199K 0.01% 184
2017
Q2 		$474K Hold
6,700
– – 0.02% 161
2017
Q1 		$455K Sell
6,700
-6,700
-50% -$471K 0.02% 164
2016
Q4 		$960K Sell
13,400
-2,900
-18% -$216K 0.04% 153
2016
Q3 		$1.29M Buy
16,300
+7,600
+87% +$617K 0.05% 134
2016
Q2 		$726K Buy
8,700
+2,500
+40% +$222K 0.03% 171
2016
Q1 		$569K Buy
6,200
+100
+2% +$9.02K 0.02% 182
2015
Q4 		$617K Sell
6,100
-700
-10% -$72.8K 0.03% 169
2015
Q3 		$667K Sell
6,800
-1,100
-14% -$122K 0.03% 161
2015
Q2 		$925K Sell
7,900
-3,700
-32% -$404K 0.04% 146
2015
Q1 		$1.14M Buy
11,600
+2,100
+22% +$213K 0.05% 135
2014
Q4 		$895K Hold
9,500
– – 0.04% 154
2014
Q3 		$1.01M Hold
9,500
– – 0.04% 134
2014
Q2 		$788K Sell
9,500
-7,500
-44% -$584K 0.03% 139
2014
Q1 		$1.2M Hold
17,000
– – 0.05% 106
2013
Q4 		$1.28M Sell
17,000
-1,200
-7% -$83.6K 0.06% 84
2013
Q3 		$1.14M Buy
18,200
+11,800
+184% +$705K 0.06% 84
2013
Q2 		$328K Buy
+6,400
New +$334K 0.02% 98

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Intact Investment Management's GILD Position: Q2 2026 in Review

Intact Investment Management increased its Gilead Sciences (GILD) stake by 78% in Q2 2026, buying an estimated $5.18M and bringing the position to 89,900 shares worth $11.4M. The position accounts for 0.32% of the portfolio, ranked #77.

Intact Investment Management first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $13M in Q3 2022. 396 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Intact Investment Management held 89,900 shares of Gilead Sciences worth $11.4M as of Q2 2026.
  • Intact Investment Management bought 39,300 Gilead Sciences shares in Q2 2026, an estimated $5.18M.
  • Gilead Sciences made up 0.32% of Intact Investment Management's portfolio in Q2 2026, its #77 holding.
  • Intact Investment Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Intact Investment Management's Gilead Sciences position peaked at $13M in Q3 2022.
  • 396 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Intact Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.